preloader icon



Apex Trader Funding - News

SASOL LIMITED: TRADING STATEMENT FOR THE FINANCIAL YEAR ENDED 30 JUNE 2024 AND RETIREMENT OF NON-EXECUTIVE DIRECTOR

JOHANNESBURG, Aug. 12, 2024 /PRNewswire/ --  Trading statement for the financial year ended 30 June 2024 Sasol's financial results for the year ended 30 June 2024 were negatively impacted by challenging market conditions, with continued pressure from depressed chemicals prices and constrained margins. However, these factors were partially offset by the stronger rand/oil price, improved refining margins and higher sales volumes. Additionally, Sasol's stronger operational performance in the fourth quarter contributed to an overall stronger performance in the second half of the year. Shareholders are referred to the annual production and sales metrics published on 22 July 2024 for further details (https://www.sasol.com/investor-centre/financial-results). Sasol's adjusted earnings before interest, tax, depreciation and amortisation (adjusted EBITDA*) for the year ended 30 June 2024 are expected to decline by between 2% and 17% from R66,3 billion in the prior year to between R54,7 billion and R64,7 billion. Earnings for the year ended 30 June 2024 decreased by more than 100%, and is impacted by the following notable non-cash adjustments: Net loss of R55,8 billion after tax (R75,4 billion gross) on remeasurement items mainly due to the following impairments**: Chemicals America Ethane value chain (Alcohols, Alumina, Ethylene Oxide, Ethylene Glycols and associated shared assets) cash generating unit (CGU) of R45,5 billion net of tax (R58,9 billion gross). Additionally, Chemicals Africa's Polyethylene, Chlor-Alkali & Polyvinyl Chloride and Wax value chain CGUs of R3,9 billion net of tax (R5,3 billion gross). The impairments are primarily driven by external conditions, including prolonged softer market pricing and outlook; Secunda liquid fuels refinery CGU of R5,7 billion net of tax (R7,8 billion gross), which remains fully impaired at 30 June 2024. Derecognition of deferred tax asset to the value of R15,3 billion, mainly relating to assessed loss carry forward on our Chemicals America operations which are not anticipated to be utilised; and Unrealised gains of R4,7 billion (before tax) on the translation of monetary assets and liabilities, and valuation of financial instruments and derivative contracts. Based on the above movements, shareholders are advised that the Group expects the earnings per share ("EPS') and headline earnings per share ("HEPS") to be lower than the comparative period. The following guidance is applicable for the 2024 financial year: Basic loss per share (LPS) is expected to be between R68,82 and R71,48 compared to the prior year basic earnings per share (EPS) of R14,00 (representing a decrease of more than 100%); ­Headline earnings per share (HEPS) are expected to be between R12,28 and R21,95 compared to the prior year HEPS of R53,75 (representing a decrease of between 59% to 77%); and ­Core headline earnings per share (CHEPS***) are expected to be between R35,03 and R43,62 compared to the prior year CHEPS of R47,71 (representing a decrease of between 9% to 27%). The financial information underpinning this trading statement ...